RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The 3.alpha. isomer of RTI-55, RTI-352, is an effective in vivo
binding ligand that reflects greater selectivity for the dopamine
transporter than is observed with RTI-55. In addition, there is
also a more rapid achievement of apparent equilibrium in the
striatal-to-cerebellar ratio (compared to RTI-55) as the ratio
peaks at about 30 min and is maintained for about 20 min
thereafter. Such apparent equilibrium is useful in developing an
approach to measuring the number of dopamine transporters present
in tissues. Moreover, these results indicate that the utilization
of 3.alpha. isomers of a variety of 3.beta.-(substituted
phenyl)tropanes will result in greater selectivity for dopamine
transporters and a more rapid of achievement of apparent
equilibrium.